MA30728B1 - Derives hydroxy-tetrahydro-naphtalenyluree - Google Patents
Derives hydroxy-tetrahydro-naphtalenylureeInfo
- Publication number
- MA30728B1 MA30728B1 MA27935A MA27935A MA30728B1 MA 30728 B1 MA30728 B1 MA 30728B1 MA 27935 A MA27935 A MA 27935A MA 27935 A MA27935 A MA 27935A MA 30728 B1 MA30728 B1 MA 30728B1
- Authority
- MA
- Morocco
- Prior art keywords
- tetrahydro
- pain
- derivatives
- naphthalene derivatives
- naphthalenyluree
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 2
- 206010053582 Bronchopneumopathy Diseases 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 206010056677 Nerve degeneration Diseases 0.000 abstract 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA30728B1 true MA30728B1 (fr) | 2009-10-01 |
Family
ID=9936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27935A MA30728B1 (fr) | 2002-05-08 | 2004-11-05 | Derives hydroxy-tetrahydro-naphtalenyluree |
Country Status (13)
| Country | Link |
|---|---|
| KR (1) | KR101000688B1 (uk) |
| AR (1) | AR039983A1 (uk) |
| CU (1) | CU23422B7 (uk) |
| DO (1) | DOP2003000642A (uk) |
| EC (1) | ECSP045413A (uk) |
| GB (2) | GB0210512D0 (uk) |
| GT (1) | GT200300102A (uk) |
| MA (1) | MA30728B1 (uk) |
| MY (1) | MY155011A (uk) |
| PE (1) | PE20040363A1 (uk) |
| PT (1) | PT1506167E (uk) |
| UA (1) | UA77301C2 (uk) |
| ZA (1) | ZA200408993B (uk) |
-
2002
- 2002-05-08 GB GBGB0210512.0A patent/GB0210512D0/en not_active Ceased
- 2002-11-21 GB GBGB0227262.3A patent/GB0227262D0/en not_active Ceased
-
2003
- 2003-04-28 PT PT03722554T patent/PT1506167E/pt unknown
- 2003-04-28 KR KR1020047017969A patent/KR101000688B1/ko not_active Expired - Fee Related
- 2003-04-28 UA UA20041210079A patent/UA77301C2/uk unknown
- 2003-05-05 GT GT200300102A patent/GT200300102A/es unknown
- 2003-05-06 MY MYPI20031696A patent/MY155011A/en unknown
- 2003-05-07 PE PE2003000445A patent/PE20040363A1/es not_active Application Discontinuation
- 2003-05-07 DO DO2003000642A patent/DOP2003000642A/es unknown
- 2003-05-08 AR ARP030101614A patent/AR039983A1/es active IP Right Grant
-
2004
- 2004-11-04 CU CU20040254A patent/CU23422B7/es unknown
- 2004-11-05 ZA ZA2004/08993A patent/ZA200408993B/en unknown
- 2004-11-05 MA MA27935A patent/MA30728B1/fr unknown
- 2004-11-08 EC EC2004005413A patent/ECSP045413A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA77301C2 (en) | 2006-11-15 |
| PE20040363A1 (es) | 2004-07-03 |
| PT1506167E (pt) | 2007-12-10 |
| GB0210512D0 (en) | 2002-06-19 |
| ECSP045413A (es) | 2005-01-03 |
| KR20040108784A (ko) | 2004-12-24 |
| GT200300102A (es) | 2004-03-17 |
| CU23422B7 (es) | 2009-09-08 |
| GB0227262D0 (en) | 2002-12-31 |
| DOP2003000642A (es) | 2003-11-15 |
| MY155011A (en) | 2015-08-28 |
| ZA200408993B (en) | 2006-01-25 |
| AR039983A1 (es) | 2005-03-09 |
| KR101000688B1 (ko) | 2010-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN05298A1 (fr) | Derives de pyrazolo-quinazoline, procede pour leur preparation et leur utilisation comme inhibiteurs de kinases | |
| JP7146809B2 (ja) | 医薬組成物の調製におけるシトクロムｂｃ１複合体阻害剤の使用 | |
| IL159299A0 (en) | Orally administered dosage forms of gaba analog prodrugs having reduced toxicity | |
| TNSN04246A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
| EA200601802A1 (ru) | Производные морфолина | |
| MX2008016525A (es) | Inhibidores heterocíclicos fusionados de d-amino ácido oxidasa. | |
| MA27491A1 (fr) | Derives de phenyl-ou heteroarylamino-alcanes comme antagonistes ou recepteur ip | |
| CY1107264T1 (el) | Αποτελεσματα καταστολης ανοσοποιησης των παραγωγων pteridine | |
| DE60315704D1 (de) | Tetrahydronaphtalen-derivate | |
| LU91281I2 (fr) | Preotact-hormone parathyroïde | |
| PL373257A1 (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| MA29566B1 (fr) | Composes chimiques | |
| MA28429B1 (fr) | Dérivés de 1H-thiéno [2,3-c] pyrazole utiles comme inhibiteurs de kinases | |
| EP4480482A3 (en) | Pyrimidines for degrading bruton's tyrosine kinase | |
| DK1572632T3 (da) | Tetrahydro-naphthalenderivater som vanilloidreceptorantagonister | |
| MXPA02011921A (es) | Inhibidores de dipeptidasa acida n-acetilada-alfa-enlazada para el tratamiento de trastornos retinianos y glaucona. | |
| MA30728B1 (fr) | Derives hydroxy-tetrahydro-naphtalenyluree | |
| EP1201240A3 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
| BRPI0410651A (pt) | composto, composição farmacêutica, e, métodos para tratar ou prevenir cáncer, degeneração macular do tipo úmida ou artrite reumatóide, vascularização aberrante, nìveis de cobre em excesso, obesidade e doença neurodegenerativa em um paciente | |
| MXPA05014143A (es) | Derivados de cumarina para el tratamiento de trastornos oftalmicos. | |
| BR0214293A (pt) | Composto e métodos para tratar um paciente que tenha, ou de prevenir um paciente de adquirir, uma doença ou condição e para produzir um composto ou um sal ou éster farmaceuticamente aceitável do mesmo | |
| ZA202204251B (en) | Compounds and compositions for the treatment of parasitic diseases | |
| HRP20030885A2 (en) | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS | |
| NO20033634L (no) | GLyT-1-inhibitorer | |
| MX2024014168A (es) | Antagonistas de at2r y usos de estos |